Year |
Citation |
Score |
2022 |
Jenkins AK, Lewis DA, Volk DW. Altered expression of microglial markers of phagocytosis in schizophrenia. Schizophrenia Research. 251: 22-29. PMID 36527956 DOI: 10.1016/j.schres.2022.12.005 |
0.684 |
|
2021 |
Roman KM, Jenkins AK, Lewis DA, Volk DW. Involvement of the nuclear factor-κB transcriptional complex in prefrontal cortex immune activation in bipolar disorder. Translational Psychiatry. 11: 40. PMID 33436571 DOI: 10.1038/s41398-020-01092-x |
0.509 |
|
2019 |
Volk DW, Lewis DA. Insights Into the Pathophysiology of Endocannabinoid Signaling in Schizophrenia. Jama Psychiatry. PMID 31166594 DOI: 10.1001/Jamapsychiatry.2019.0844 |
0.646 |
|
2019 |
Jenkins A, Locker A, Volk D. F169. Increased mRNA Levels of Microglial Markers of Phagocytosis in Schizophrenia Biological Psychiatry. 85: S278-S279. DOI: 10.1016/J.Biopsych.2019.03.706 |
0.551 |
|
2018 |
Volk DW, Moroco AE, Roman KM, Edelson JR, Lewis DA. The Role of the Nuclear Factor-κB Transcriptional Complex in Cortical Immune Activation in Schizophrenia. Biological Psychiatry. PMID 30082065 DOI: 10.1016/J.Biopsych.2018.06.015 |
0.573 |
|
2018 |
Gomes FV, Edelson JR, Volk DW, Grace AA. Altered brain cannabinoid 1 receptor mRNA expression across postnatal development in the MAM model of schizophrenia. Schizophrenia Research. PMID 29705007 DOI: 10.1016/J.Schres.2018.04.030 |
0.542 |
|
2016 |
Volk DW. Role of microglia disturbances and immune-related marker abnormalities in cortical circuitry dysfunction in schizophrenia. Neurobiology of Disease. PMID 28007586 DOI: 10.1016/J.Nbd.2016.12.019 |
0.614 |
|
2016 |
Volk DW, Gonzalez-Burgos G, Lewis DA. l-Proline, GABA Synthesis and Gamma Oscillations in Schizophrenia. Trends in Neurosciences. PMID 27832914 DOI: 10.1016/J.Tins.2016.10.009 |
0.709 |
|
2016 |
Datta D, Arion D, Roman KM, Volk DW, Lewis DA. Altered Expression of ARP2/3 Complex Signaling Pathway Genes in Prefrontal Layer 3 Pyramidal Cells in Schizophrenia. The American Journal of Psychiatry. appiajp201616020204. PMID 27523502 DOI: 10.1176/Appi.Ajp.2016.16020204 |
0.635 |
|
2016 |
Volk DW, Sampson AR, Zhang Y, Edelson JR, Lewis DA. Cortical GABA markers identify a molecular subtype of psychotic and bipolar disorders. Psychological Medicine. 1-12. PMID 27328999 DOI: 10.1017/S0033291716001446 |
0.673 |
|
2016 |
Volk DW, Edelson JR, Lewis DA. Altered expression of developmental regulators of parvalbumin and somatostatin neurons in the prefrontal cortex in schizophrenia. Schizophrenia Research. PMID 26972474 DOI: 10.1016/J.Schres.2016.03.001 |
0.722 |
|
2015 |
Kimoto S, Glausier JR, Fish KN, Volk DW, Bazmi HH, Arion D, Datta D, Lewis DA. Reciprocal Alterations in Regulator of G Protein Signaling 4 and microRNA16 in Schizophrenia. Schizophrenia Bulletin. PMID 26424323 DOI: 10.1093/Schbul/Sbv139 |
0.825 |
|
2015 |
Chung DW, Volk DW, Arion D, Zhang Y, Sampson AR, Lewis DA. Dysregulated ErbB4 Splicing in Schizophrenia: Selective Effects on Parvalbumin Expression. The American Journal of Psychiatry. appiajp201515020150. PMID 26337038 DOI: 10.1176/Appi.Ajp.2015.15020150 |
0.738 |
|
2015 |
Volk DW, Lewis DA. The Role of Endocannabinoid Signaling in Cortical Inhibitory Neuron Dysfunction in Schizophrenia. Biological Psychiatry. PMID 26210060 DOI: 10.1016/J.Biopsych.2015.06.015 |
0.747 |
|
2015 |
Volk DW, Chitrapu A, Edelson JR, Roman KM, Moroco AE, Lewis DA. Molecular Mechanisms and Timing of Cortical Immune Activation in Schizophrenia. The American Journal of Psychiatry. appiajp201515010019. PMID 26133963 DOI: 10.1176/Appi.Ajp.2015.15010019 |
0.612 |
|
2015 |
Hoftman GD, Volk DW, Bazmi HH, Li S, Sampson AR, Lewis DA. Altered cortical expression of GABA-related genes in schizophrenia: illness progression vs developmental disturbance. Schizophrenia Bulletin. 41: 180-91. PMID 24361861 DOI: 10.1093/Schbul/Sbt178 |
0.706 |
|
2014 |
Volk DW, Chitrapu A, Edelson JR, Lewis DA. Chemokine receptors and cortical interneuron dysfunction in schizophrenia. Schizophrenia Research. PMID 25464914 DOI: 10.1016/J.Schres.2014.10.031 |
0.803 |
|
2014 |
Volk DW, Eggan SM, Horti AG, Wong DF, Lewis DA. Reciprocal alterations in cortical cannabinoid receptor 1 binding relative to protein immunoreactivity and transcript levels in schizophrenia. Schizophrenia Research. 159: 124-9. PMID 25107849 DOI: 10.1016/J.Schres.2014.07.017 |
0.838 |
|
2014 |
Volk DW, Lewis DA. Early developmental disturbances of cortical inhibitory neurons: contribution to cognitive deficits in schizophrenia. Schizophrenia Bulletin. 40: 952-7. PMID 25053651 DOI: 10.1093/Schbul/Sbu111 |
0.745 |
|
2014 |
Volk DW, Edelson JR, Lewis DA. Cortical inhibitory neuron disturbances in schizophrenia: role of the ontogenetic transcription factor Lhx6. Schizophrenia Bulletin. 40: 1053-61. PMID 24837792 DOI: 10.1093/Schbul/Sbu068 |
0.769 |
|
2014 |
Siegel BI, Sengupta EJ, Edelson JR, Lewis DA, Volk DW. Elevated viral restriction factor levels in cortical blood vessels in schizophrenia. Biological Psychiatry. 76: 160-7. PMID 24209773 DOI: 10.1016/J.Biopsych.2013.09.019 |
0.774 |
|
2014 |
Volk DW, Lewis DA. Schizophrenia Rosenberg's Molecular and Genetic Basis of Neurological and Psychiatric Disease: Fifth Edition. 1293-1299. DOI: 10.1016/B978-0-12-410529-4.00105-4 |
0.635 |
|
2013 |
Volk DW, Lewis DA. Prenatal ontogeny as a susceptibility period for cortical GABA neuron disturbances in schizophrenia. Neuroscience. 248: 154-64. PMID 23769891 DOI: 10.1016/J.Neuroscience.2013.06.008 |
0.758 |
|
2013 |
Volk DW, Siegel BI, Verrico CD, Lewis DA. Endocannabinoid metabolism in the prefrontal cortex in schizophrenia. Schizophrenia Research. 147: 53-7. PMID 23561296 DOI: 10.1016/J.Schres.2013.02.038 |
0.807 |
|
2013 |
Curley AA, Eggan SM, Lazarus MS, Huang ZJ, Volk DW, Lewis DA. Role of glutamic acid decarboxylase 67 in regulating cortical parvalbumin and GABA membrane transporter 1 expression: implications for schizophrenia. Neurobiology of Disease. 50: 179-86. PMID 23103418 DOI: 10.1016/J.Nbd.2012.10.018 |
0.838 |
|
2012 |
Volk DW, Matsubara T, Li S, Sengupta EJ, Georgiev D, Minabe Y, Sampson A, Hashimoto T, Lewis DA. Deficits in transcriptional regulators of cortical parvalbumin neurons in schizophrenia. The American Journal of Psychiatry. 169: 1082-1091. PMID 22983435 DOI: 10.1176/Appi.Ajp.2012.12030305 |
0.796 |
|
2012 |
Lewis DA, Curley AA, Glausier JR, Volk DW. Cortical parvalbumin interneurons and cognitive dysfunction in schizophrenia. Trends in Neurosciences. 35: 57-67. PMID 22154068 DOI: 10.1016/J.Tins.2011.10.004 |
0.826 |
|
2012 |
Eggan SM, Lazarus MS, Stoyak SR, Volk DW, Glausier JR, Huang ZJ, Lewis DA. Cortical glutamic acid decarboxylase 67 deficiency results in lower cannabinoid 1 receptor messenger RNA expression: implications for schizophrenia. Biological Psychiatry. 71: 114-9. PMID 22036037 DOI: 10.1016/J.Biopsych.2011.09.014 |
0.823 |
|
2012 |
Volk DW, Radchenkova PV, Walker EM, Sengupta EJ, Lewis DA. Cortical opioid markers in schizophrenia and across postnatal development. Cerebral Cortex (New York, N.Y. : 1991). 22: 1215-23. PMID 21810780 DOI: 10.1093/Cercor/Bhr202 |
0.753 |
|
2011 |
Curley AA, Arion D, Volk DW, Asafu-Adjei JK, Sampson AR, Fish KN, Lewis DA. Cortical deficits of glutamic acid decarboxylase 67 expression in schizophrenia: clinical, protein, and cell type-specific features. The American Journal of Psychiatry. 168: 921-9. PMID 21632647 DOI: 10.1176/Appi.Ajp.2011.11010052 |
0.86 |
|
2010 |
Volk DW, Lewis DA. Prefrontal cortical circuits in schizophrenia. Current Topics in Behavioral Neurosciences. 4: 485-508. PMID 21312410 DOI: 10.1007/7854_2010_44 |
0.712 |
|
2010 |
Volk DW, Eggan SM, Lewis DA. Alterations in metabotropic glutamate receptor 1α and regulator of G protein signaling 4 in the prefrontal cortex in schizophrenia. The American Journal of Psychiatry. 167: 1489-98. PMID 20889653 DOI: 10.1176/Appi.Ajp.2010.10030318 |
0.86 |
|
2009 |
Maldonado-Avilés JG, Curley AA, Hashimoto T, Morrow AL, Ramsey AJ, O'Donnell P, Volk DW, Lewis DA. Altered markers of tonic inhibition in the dorsolateral prefrontal cortex of subjects with schizophrenia. The American Journal of Psychiatry. 166: 450-9. PMID 19289452 DOI: 10.1176/Appi.Ajp.2008.08101484 |
0.84 |
|
2008 |
Hashimoto T, Arion D, Unger T, Maldonado-Avilés JG, Morris HM, Volk DW, Mirnics K, Lewis DA. Alterations in GABA-related transcriptome in the dorsolateral prefrontal cortex of subjects with schizophrenia. Molecular Psychiatry. 13: 147-61. PMID 17471287 DOI: 10.1038/Sj.Mp.4002011 |
0.852 |
|
2005 |
Volk DW, Lewis DA. GABA Targets for the Treatment of Cognitive Dysfunction in Schizophrenia. Current Neuropharmacology. 3: 45-62. PMID 22545031 DOI: 10.2174/1570159052773396 |
0.697 |
|
2005 |
Lewis DA, Hashimoto T, Volk DW. Cortical inhibitory neurons and schizophrenia. Nature Reviews. Neuroscience. 6: 312-24. PMID 15803162 DOI: 10.1038/Nrn1648 |
0.738 |
|
2004 |
Tamminga C, Hashimoto T, Volk DW, Lewis DA. GABA neurons in the human prefrontal cortex. The American Journal of Psychiatry. 161: 1764. PMID 15465968 DOI: 10.1176/Ajp.161.10.1764 |
0.606 |
|
2004 |
Lewis DA, Volk DW, Hashimoto T. Selective alterations in prefrontal cortical GABA neurotransmission in schizophrenia: a novel target for the treatment of working memory dysfunction. Psychopharmacology. 174: 143-50. PMID 15205885 DOI: 10.1007/S00213-003-1673-X |
0.723 |
|
2003 |
Hashimoto T, Volk DW, Eggan SM, Mirnics K, Pierri JN, Sun Z, Sampson AR, Lewis DA. Gene expression deficits in a subclass of GABA neurons in the prefrontal cortex of subjects with schizophrenia. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 23: 6315-26. PMID 12867516 DOI: 10.1523/Jneurosci.23-15-06315.2003 |
0.851 |
|
2003 |
Volk DW, Lewis DA. Effects of a mediodorsal thalamus lesion on prefrontal inhibitory circuitry: implications for schizophrenia. Biological Psychiatry. 53: 385-9. PMID 12614991 DOI: 10.1016/S0006-3223(02)01547-0 |
0.668 |
|
2003 |
Hashimoto T, Volk D, Eggan S, Pierri J, Sun Z, Sampson A, Lewis D. Altered gene expression in parvalbumin-containing GABA neurons in the prefrontal cortex of subjects with schizophrenia Schizophrenia Research. 60: 71. DOI: 10.1016/S0920-9964(03)80597-2 |
0.857 |
|
2002 |
Volk DW, Lewis DA. Impaired prefrontal inhibition in schizophrenia: relevance for cognitive dysfunction. Physiology & Behavior. 77: 501-5. PMID 12526990 DOI: 10.1016/S0031-9384(02)00936-8 |
0.742 |
|
2002 |
Volk DW, Pierri JN, Fritschy JM, Auh S, Sampson AR, Lewis DA. Reciprocal alterations in pre- and postsynaptic inhibitory markers at chandelier cell inputs to pyramidal neurons in schizophrenia. Cerebral Cortex (New York, N.Y. : 1991). 12: 1063-70. PMID 12217970 DOI: 10.1093/Cercor/12.10.1063 |
0.747 |
|
2001 |
Volk DW, Austin MC, Pierri JN, Sampson AR, Lewis DA. GABA transporter-1 mRNA in the prefrontal cortex in schizophrenia: Decreased expression in a subset of neurons American Journal of Psychiatry. 158: 256-265. PMID 11156808 DOI: 10.1176/Appi.Ajp.158.2.256 |
0.732 |
|
2000 |
Volk DW, Austin MC, Pierri JN, Sampson AR, Lewis DA. Decreased glutamic acid decarboxylase67 messenger RNA expression in a subset of prefrontal cortical gamma-aminobutyric acid neurons in subjects with schizophrenia. Archives of General Psychiatry. 57: 237-45. PMID 10711910 DOI: 10.1001/Archpsyc.57.3.237 |
0.767 |
|
2000 |
Volk D, Austin M, Pierri J, Lewis D. 51. Altered GABA transporter-1 mRNA expression in prefrontal cortical neurons in schizophrenia Biological Psychiatry. 47: S16. DOI: 10.1016/S0006-3223(00)00313-9 |
0.735 |
|
1999 |
Lewis DA, Pierri JN, Volk DW, Melchitzky DS, Woo TU. Altered GABA neurotransmission and prefrontal cortical dysfunction in schizophrenia. Biological Psychiatry. 46: 616-26. PMID 10472415 DOI: 10.1016/S0006-3223(99)00061-X |
0.774 |
|
1996 |
Anderson SA, Volk DW, Lewis DA. Increased density of microtubule associated protein 2-immunoreactive neurons in the prefrontal white matter of schizophrenic subjects. Schizophrenia Research. 19: 111-9. PMID 8789909 DOI: 10.1016/0920-9964(96)88521-5 |
0.595 |
|
Show low-probability matches. |